Category Archives: Spinal Cord Injury Treatment

Despite pharmacological treatment, many individuals with multiple sclerosis (MS) continue to experience symptoms and medication side effects. Exercise holds promise for MS, but changes in brain structure following exercise have not been thoroughly investigated, and important cognitive and psychosocial variables are rarely primary outcomes Continue reading →

Berwyn, Pennsylvania--(Newsfile Corp. - March 10, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced the Japan Patent Office (JPO) granted the Company's patent (2018-527851) for the treatment or prevention of acute brain or nerve injury by administering ANVS405. Continue reading →

Introduction Rheumatoid arthritis (RA) is a chronic, autoimmune disease that affects about 1% of the global population. It is characterized by synovial joint tissue inflammation and pain, and by potential direct and indirect involvement of other organ systems, such as the cardiovascular, pulmonary, and skeletal systems, and RA is often associated with a significant psychological impact.1,2 The pathogenesis of RA is driven by a complex combination of inflammatory cells and mediators, which are the targets of disease-modifying agents used in the management of RA. Pain is the hallmark symptom of RA and can be debilitating. Continue reading →

Sharing Knowledge, Resources and Experience For 40 years, ISRT and the Reeve Foundation have shared a commitment to bringing therapeutics that restore function and independence to the spinal cord injury (SCI) community. This new alliance, inspired by the speed at which solutions for COVID-19 are being delivered, seeks to take a coordinated, global approach to accelerating the processes of bringing meaningful therapeutics to those living with SCI. The new Chief Executive of ISRT, Harvey Sihota, commented, "We have seen major advances in our understanding of spinal cord biology, including improvements in diagnostics, acute treatment and rehabilitation. Continue reading →

AJ Quetta will be transferred to the Shepherd Center in Atlanta on Monday, as he continues to rehab following a severe spinal cord injury he suffered in a high school hockey game in late January. Quetta, a senior at Bishop Feehan High School who slammed headfirst into the boards in a game against Pope Francis, started at Baystate Medical Center in Springfield and was then sent to Mass Continue reading →

"This series was developed by our organizations to serve individuals in the community who lack resources for counseling and need guidance regarding emotional healing. Regardless of the rehabilitation and counseling the person may or may not have received after a spinal cord injury, returning home can be an isolating and challenging experience," said Diane M. Johnston, MSPT, Director of Professional Education at Shepherd Center. Continue reading →

Market Summary Follow InVivo Therapeutics Holdings Corp. is a InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury Continue reading →

The winter months are a perfect time to grab a seat on your couch, prop your feet up with a warm blanket and relax. Continue reading →

DUBLIN--(BUSINESS WIRE)--The "Cell Therapy Biomanufacturing: Global Markets" report has been added to ResearchAndMarkets.com's offering. This research report presents an in-depth analysis of the global cell therapy biomanufacturing market by product type, application and region Continue reading →

Feb. 8, 2021 13:00 UTC CARLSBAD, Calif.--(BUSINESS WIRE)-- Lineage Cell Therapeutics, Inc.(NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it has entered into an exclusive option and license agreement with Neurgain Technologies, Inc. (Neurgain), a medical device company that is commercializing technology developed by neurosurgeons at the University of California San Diego (UC San Diego) Continue reading →